BVF I GP LLC
CIK 1803805 · last filed 2025-01-14
BVF I GP LLC is a corporate insider who has filed 14 SEC Form 4 insider transactions across 10 companies since 2020. The most recent filing, for OLMA, was dated Jan 14, 2025. Across all open-market trades the lifetime net is +$618.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $191.0M across reported positions. The firm reports its address in San Francisco, CA. 159 SEC filings were submitted jointly with BVF GP HOLDINGS LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$191.02M
10
14
$618.09M
Filer Profile
SAN FRANCISCO, CA 94104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OLMA | Director | 2,103,522 | $8.75 | $18.41M | $0 | 1 | 2025-01-14 |
| FDMT | 87,911 | $14.47 | $1.27M | $0 | 1 | 2024-11-13 | |
| CGEM | 392,808 | $14.81 | $5.82M | $100.64M | 2 | 2023-01-19 | |
| RAIN | Director | 1,367,838 | $1.00 | $1.37M | $190.50M | 2 | 2022-11-10 |
| KYMR | Director | 1,466,364 | $111.95 | $164.16M | $151.66M | 2 | 2022-05-09 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | 534,847 | $0.04 | $23.9K | -$121.33M | 1 | 2021-02-16 | |
| Merus N.V. (MRUS) Delisted | 10%+ Owner | 382,784 | $90.00 | $34.45M | $230.43M | 2 | 2020-12-22 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 37,124 | $15.70 | $582.8K | $32.94M | 1 | 2020-11-06 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | 10%+ Owner | 541,084 | $38.00 | $20.56M | $12.04M | 1 | 2020-05-18 |
| XOMA Royalty Corp (XOMA) Delisted | 10%+ Owner | 1,335,192 | $40.17 | $53.63M | $21.22M | 1 | 2020-03-17 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-14 | OLMA | Mixed | −4,200,000 | $0 | EDGAR |
| 2024-11-13 | FDMT | Other (J) | −56,800,000 | $0 | EDGAR |
| 2023-01-19 | CGEM | Other (J) | −64,000,000 | $0 | EDGAR |
| 2022-11-10 | RAIN | Buy (P) | +17,103,580 | $99.71M | EDGAR |
| 2022-05-16 | CGEM | Buy (P) | +11,099,000 | $100.64M | EDGAR |
| 2022-05-09 | KYMR | Buy (P) | +2,500,000 | $48.65M | EDGAR |
| 2022-01-26 | KYMR | Buy (P) | +2,727,670 | $103.01M | EDGAR |
| 2021-07-06 | RAIN | Buy (P) | +5,870,020 | $90.79M | EDGAR |
| 2021-02-16 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Sell (S) | −22,600,850 | -$121.33M | EDGAR |
| 2020-12-22 | Merus N.V. (MRUS) Delisted | Buy (P) | +1,600,000 | $25.68M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.